# Special Drug Use Investigation of Glucobay OD

> **NCT01685502** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2289 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Glucobay ODT (Acarbose, BAYG5421)

## Key facts

- **NCT ID:** NCT01685502
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-09
- **Final completion:** 2014-08
- **Target enrollment:** 2289 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685502, "Special Drug Use Investigation of Glucobay OD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01685502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*